Evidentiary Considerations for Integration of Biomarkers in Drug Development Symposium Evidentiary Considerations for Integration of Biomarkers in Drug Development Symposium On August 21st, the University of Maryland&
June 5, 2015 Migrating a PRO Instrument This webinar provides a detailed description of the process for conducting paper to ePRO migration, mode-specific migrations, usab
April 13, 2015 Intro to ePRO – Part II This webinar provides an overview of current ePRO data collection modes, the mode selection process, key considerations for select
January 12, 2015 Intro to ePRO – Part I This webinar provides an overview of the ePRO Consortium, describes the various modes of PRO data capture, and discusses the trend
Dr. Brumfield’s Remarks at Partnering for Cures Dr. Martha Brumfield, C-Path’s President and CEO, participated in a panel discussion on November 17, 2014, “Playing ni
The Honorable Jim Greenwood discusses the art and science of multi-stakeholder collaborations The Honorable Jim Greenwood, President and CEO of Biotechnology Industry Organization (BIO) and C-Path Board member, participated